Biorelevant compositions
A related, compositional technology for biological testing, testing pharmaceutical formulations, emulsion delivery, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0260] Typical biorelevant powder composition for the preparation of human FaSSIF (i.e. FaSSIF-V3 human) preparation
[0261] About 2 g of a solid biorelevant powder composition for manufacturing FaSSIF-V3 human was prepared by dissolving 1.622 g of sodium taurocholate in 10 ml of purified water at room temperature using a magnetic stirrer. After the sodium taurocholate was completely dissolved and a clear solution was obtained, 10 ml of t-butanol was added to the solution. Next, dissolve 0.009 g of diacyl phospholipids (especially PC) and 0.199 g of monoacyl phospholipids (especially diacyl phospholipids mixed with 50%-90% of monoacyl PC from partial enzyme digestion) into the solution Medium (alternatively the lipid material is added in steps). After the lipid component was completely dissolved, a clear to slightly yellow solution was obtained, and 0.128 g of sodium oleate was added to the solution. Transfer the clear to slightly yellow solution into suitable freeze-dr...
Embodiment 2
[0263] Preparation of human FaSSIF (i.e. FaSSIF-V3 human) by the solid bio-relevant composition shown in Example 1 kind)
[0264]
[0265] * Partially digested diacylphospholipids contain approximately 80 wt% monoacyl PC
[0266] 1.741 g of the homogeneous powder composition from Example 1 was dissolved in maleic acid buffer containing buffer and osmotic agent (Example 14). Adjust the pH of the biorelevance medium to 6.7.
[0267] Alternatively, an equivalent weight of surfactant may be used in a liquid composition instead of a powder composition, such as an aqueous concentrated solution containing 10% to 60% by weight of surfactant and optional co-surfactant.
[0268] Alternatively, the ingredients may be added separately.
Embodiment 3
[0270] Preparation of human FaSSIF (i.e. FaSSIF-V3 human) by the solid bio-relevant composition shown in Example 1 kind)
[0271]
[0272]
[0273] * Partially digested diacylphospholipids contain approximately 80 wt% monoacyl PC
[0274] 1.87 g of the homogeneous powder composition from Example 1 was dissolved in maleic acid buffer containing buffer and osmotic agent (Example 13). Adjust the pH of the biorelevance medium to 6.5.
[0275] Alternatively 3.5mmol of surfactant may be used in a concentrated aqueous solution containing 10% to 60% by weight of surfactant to replace the powder composition.
[0276] Alternatively, the ingredients may be added separately to prepare the fasted state medium.
PUM
| Property | Measurement | Unit |
|---|---|---|
| surface tension | aaaaa | aaaaa |
| particle size | aaaaa | aaaaa |
| density | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 